• Mashup Score: 1

    The neoadjuvant and adjuvant use of immune checkpoint inhibitors (ICIs) in early stage non-small cell lung cancer (NSCLC) is increasing, with pembrolizumab approved as adjuvant therapy following surgical resection and chemotherapy by the U.S. Food and Drug Administration in early 2023. However, clinical trials of these agents have several key limitations including the use of surrogate endpoints…

    Tweet Tweets with this article
    • Key Question in #KN671 is how many people on control arm who progressed got Pembro+chemo (vs. chemo alone which is not SOC)? Here is some data from prior trials in our OA paper 57% of treated controls got CPI. That is poor #ASCO23 OS is meaningless https://t.co/k6Rl54vUgs https://t.co/El7cz5eMWg

  • Mashup Score: 1

    While loneliness has been linked to various mental and physical health problems, the sense in which loneliness is a cause of these conditions has so far attracted little philosophical attention. This paper aims to fill this gap by analyzing research on health effects of loneliness and therapeutic interventions through current approaches to causality. To deal with the problem of causality between…

    Tweet Tweets with this article
    • Loneliness as Cause https://t.co/l4BzRhqF6O via @ElenaPopaPhi